Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03505021
Brief Title: Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS (REFALS)

First Submitted : April 16, 2018
First Submitted that Met QC Criteria : April 16, 2018
First Posted : April 20, 2018

Last Update Submitted that Met QC Criteria : February 5, 2019
Last Update Posted : February 6, 2019